| Tag | Content |
|---|
EnhancerAtlas ID | HS034-14844 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr19:16364230-16365170 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr19:16364614-16364624 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr19:16364614-16364624 | GGCACGTGCC | - | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_32188 | chr19:16363992-16365245 | Gastric | | SE_54102 | chr19:16364502-16365168 | Spleen | | SE_62181 | chr19:16358035-16374797 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I016253 | chr19 | 16364161 | 16365046 |
|
Enhancer Sequence | ACACAGATAT AACACATAGA TGCACACCAA GCACACACAA CACACACAGA CACACAAAAC 60
AAAACTACAC ACACAACACA CAGACACACA ACATGCACAG AGACACAAGC ATACAACAGC 120
CACAGAGACA CACAGACACC ATGCATACAA CACAGACATA CACATACATC GCTTGAACCC 180
GGAAGGCGGA GGTTGCAGTG AGCCAAGATC GTGCCACTGC ACTCCAGCCT GGGTGACAGA 240
GCGAGACACC GTCTCAAAAA AAAAAAGCCC ATTTTGCAGA AGAAAACTGA GGTCAGAGAG 300
CAGAGGCAAT GTCCCCAAGC TCTGAATAGT CAGGAGTGAG CTGGAGCCAG GACCTTCACG 360
TGGCAGGGAC ACAGGGCAAG GACTGGCACG TGCCAGCTCC CAAGACAGCA GGCTGGGAGC 420
CTCCCTGCAG CCCAGAACAT TCCCATCCCC ACGGCAGTTC CTGCAGGGCC CCTCCCCCGC 480
CCCGCCTGCC CTGACGCTGA GCTGAGCACA TTTCCCATCC CACCCCTGGC TCTGTTCCAT 540
TCCAAGAGAA ACAGGTTGCA CCTGCACAGT TCCCAGAAGG CCCTGGGCAG CAGGAGGCCA 600
GCCACGTGAG TGGGTGTGTG TGGAGACGTG CAGTCACATT GCAGCCCCCA CCATGCCACT 660
GCGCAGGAGG AGCAGGGCCA CGGGTAACAG AGCCACTAAG AGGGGCGTGT GGGGCACTGA 720
GCACTCAAGC ACTGGAGCCA GCCAGACCTG AGTACCACCC AGGCTCAGCC ACTTGCCAGC 780
CTTTACCTCA AAGGAGGGAG GAGGGTTTTT TTTTTTTTTT TTTTTTTGAG AGTCTCACTC 840
TGTCACCCAG GCTGGAGTGC AGTGGTGTGA TCTCGGCTCA CTGCAACCTC TACCTCCTGA 900
GTTCAAGCAA TTCTGTCTCA GCCTCCCTAG TAGCTGGGAT 940
|
